Clinical Trial Update: Adjuvant Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

This report notes the completion of a Phase 2 trial evaluating adjuvant low-dose total body irradiation in elderly patients with diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Aarhus | Conditions: Non Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED